CV Sciences (CVSI)
(Delayed Data from OTC)
$0.10 USD
+0.02 (23.13%)
Updated Jun 5, 2024 02:51 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for CV Sciences, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1 | 1 | 1 | 5 | 10 |
Receivables | 0 | 1 | 2 | 1 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 6 | 7 | 9 | 9 | 10 |
Other Current Assets | 1 | 3 | 2 | 2 | 11 |
Total Current Assets | 8 | 11 | 14 | 17 | 32 |
Net Property & Equipment | 0 | 1 | 2 | 3 | 4 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 1 | 7 | 7 |
Deposits & Other Assets | 0 | 1 | 1 | 1 | 1 |
Total Assets | 9 | 13 | 18 | 31 | 53 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 1 | 0 | 0 |
Accounts Payable | 2 | 2 | 3 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 1 | 0 | 2 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 10 | 11 | 10 | 11 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 6 | 13 | 14 | 14 | 13 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 1 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 6 | 14 | 15 | 19 | 24 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 87 | 87 | 83 | 75 | 71 |
Retained Earnings | -85 | -88 | -79 | -64 | -42 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3 | -1 | 4 | 11 | 29 |
Total Liabilities & Shareholder's Equity | 9 | 13 | 18 | 31 | 53 |
Total Common Equity | 3 | -1 | 4 | 11 | 29 |
Shares Outstanding | 163.70 | 152.60 | 119.00 | 102.20 | 99.40 |
Book Value Per Share | 0.02 | -0.01 | 0.03 | 0.11 | 0.29 |
Fiscal Year End for CV Sciences, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1 | 1 | 2 | 2 | 1 |
Receivables | 1 | 0 | 1 | 1 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 6 | 6 | 6 | 6 | 7 |
Other Current Assets | 0 | 1 | 0 | 0 | 2 |
Total Current Assets | 7 | 8 | 8 | 9 | 10 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 8 | 9 | 10 | 10 | 11 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 2 | 3 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 3 | 3 | 4 | 3 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 6 | 6 | 6 | 6 | 6 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 6 | 6 | 6 | 6 | 6 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 88 | 87 | 87 | 87 | 87 |
Retained Earnings | -85 | -85 | -84 | -83 | -82 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 2 | 3 | 3 | 4 | 5 |
Total Liabilities & Shareholder's Equity | 8 | 9 | 10 | 10 | 11 |
Total Common Equity | 2 | 3 | 3 | 4 | 5 |
Shares Outstanding | 163.20 | 163.70 | 155.10 | 155.10 | 152.10 |
Book Value Per Share | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 |